ClinicalTrials.gg
Sign In

Drug

Birelentinib clinical trials

Also written DZD8586.

studies test it
12
open now
7
in phase 3
2
first study started
2021

Keep track of what changes. Save the birelentinib studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Birelentinib
5

Development codes

DZD8586
10

Combined with it in one product

DZD8586+R-CHOP
1
DZD8586+R-GemOx
1

Studies by the year they started

12 studies that test it; most in 2026 (4)

Studies that test birelentinib, by start year
YearStudies
20211
20221
20231
20242
20253
20264

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
7
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it.

Lymphoma, Non-Hodgkin
4
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Purpura, Thrombocytopenic, Idiopathic
1

Who runs them

Industry 12 · Other 0

Dizal Pharmaceuticals (11) · Dizal (Jiangsu) Pharmaceutical Co., Ltd. (1)

Often tested with

Tested in the same studies.

Rabeprazole (1) · R-CHOP Regimen (1) · R-GemOx Regimen (1)

Studies

Open first, then newest update. How each study uses birelentinib is read from its arms, and is right about nine times in ten.

Testing it · 12

Codes

What other systems call birelentinib · ClinicalTrials.gg INT018643

  • UNII (FDA) Z2F599L9GDBIRELENTINIBConfirmed FDA, Wikidata
  • Wikidata Q140528727birelentinibConfirmed FDA, Wikidata
  • NCI Thesaurus C215277BirelentinibOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.